@article{18a7a58c96224c9483689de0e1d249ab,
title = "Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy",
keywords = "cancer, HMGB1, immunotherapy, oncolytic adenovirus, prognostic markers, predictive markers, tumor biomarkers, REFRACTORY SOLID TUMORS, IMMUNOGENIC CELL-DEATH, REGULATORY T-CELLS, GROUP BOX 1, CANCER-PATIENTS, ADENOVIRUS, CHEMOTHERAPY, RESPONSES, THERAPY, RAGE, 3122 Cancers, 3111 Biomedicine",
author = "Ilkka Liikanen and Anniina Koski and Maiju Merisalo-Soikkeli and Otto Hemminki and Minna Oksanen and Kalevi Kairemo and Timo Joensuu and Anna Kanerva and Akseli Hemminki",
year = "2015",
month = mar,
doi = "10.4161/2162402X.2014.989771",
language = "English",
volume = "4",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "TAYLOR & FRANCIS INC",
number = "3",
}